The need for registry‐based studies in diabetes and stroke: A unique opportunity to understand whether diabetic treatments improve post‐stroke outcome-Reference-Cited by-同舟云学术

The need for registry‐based studies in diabetes and stroke: A unique opportunity to understand whether diabetic treatments improve post‐stroke outcome

Published:2024-04 Issue:7 Volume:26 Page:2527-2530
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Darsalia Vladimer¹^ORCID,Vercalsteren Ellen¹,Karampatsi Dimitra¹,Romanitan Mihaela Oana¹,Mazya Michael V.²³,Nyström Thomas¹^ORCID,Patrone Cesare¹^ORCID

Affiliation:

1. NeuroCardioMetabol Group, Department of Clinical Science and Education Södersjukhuset, Internal Medicine, Karolinska Institutet Stockholm Sweden

2. Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden

3. Department of Neurology Karolinska University Hospital Stockholm Sweden

Funder

Hjärnfonden

Swedish Stroke Foundation

Vetenskapsrådet

Hjärt-Lungfonden

Publisher

Wiley

Reference23 articles.

1. Primary stroke prevention worldwide: translating evidence into action

2. How can we improve the pre-clinical development of drugs for stroke?

3. Neuroprotection during Thrombectomy for Acute Ischemic Stroke: A Review of Future Therapies

4. Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6

5. Changes in Functional Outcome Over the First Year After Stroke

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study;Diabetes, Obesity and Metabolism;2024-08-12